gct 2024 group picture ohne footer

Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course, 4th edition

Coordinators: Eric J. Kremer (CNRS, IGMM Université de Montpellier, FR), Joaquim Vives (Banc de Sang I Teixits, ES), Margarida Serra (iBET, PT)

Applications are open!

Acceptance decisions will be announced in June 2025.

Gene and cell products are paving the way towards more effective therapeutics for unmet medical needs. Currently, one of the main translational challenges is a consistent and cost-effective supply of these complex medicinal products. Taking into account the interest raised by ESACT members and other learned societies, we are organizing the 5th Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course in Llafranc, Costa Brava/Spain, in September 2025. ESACT is introducing this activity as one more contribution to the community targeting the use of viral vectors, stem cells and immune cells for therapy. This course is intended for Ph.D. students, post-docs, junior scientists, engineers and clinicians searching to improve their understanding of the development and manufacturing of gene and cell therapy products.

Course Topics

The speakers will address key bioprocessing aspects, analytical toolsets to assess the quantity and quality attributes, and regulatory challenges for the manufacturing of ATMPs, providing also a solid fundamental basis on vectorology and stem cell biology. The course is designed as an interactive 5-day program with the number of participants restricted to 30 to foster interaction among speakers and attendees. The course comprises lectures covering the main topics of Gene & Cell Therapy:

The course comprises lectures covering the main topics of Animal Cell Technology:

  • Introduction to Gene Therapy & to Cell Therapy
  • Immunology, Virology & Vectorology
  • Cell Line Development for Viruses Production
  • Stem Cell Biology
  • Gene Modification of Cells for Therapy
  • Bioreactor scale-up, scale down and single use Bioreactor for Cells based Products & Viral Vectors
  • Downstream processing for Cells based Products & Viral Vectors
  • Omics in Bioprocess Development
  • Manufacturing Cells based Products & Viral Vectors
  • Novel Modalities in Gene & Cell Therapy
  • Scale-up and the Role of Automation in Gene & Cell Therapy
  • Process & Product Analytics
  • Health Technology Assessment/Economics
  • Decision Tools

Program

The program has also slots dedicated to presentation of case studies by lecturers, workshops, exercises and discussion groups with the lecturers.

The full program of the course can be downloaded here (as of April 2025,  topics may change):

Lecturers

image

Eric J. Kremer

image

Margarida Serra

gct joaquim vives
Coordinator

Joaquim Vives

gct dominik

Dominik Bruecher

gct coroadinha

Ana Coroadinha

avatar white

Kerry Fisher

gct martin

Chantal Martin

gct mcgrath

Eoin McGrath

gct segura

Mercedes Segura

avatar white

Ioannis Papantouniou

All other lecturers to be announced

Detailed Course Information

Testimonials

picture paloma fuentes gct 2024

IMPACT – Ponti

ficia Universidad Católica de Valparaíso  

FAQ

Date:

21 – 25 September 2025

Application Deadline:

16 May 2025

Registration Fee:

Academia: 1.250,00 EUR
Industry: 1.950,00 EUR 

Address:
Passeig de Cipsela 1
17211 Llafranc, Girona, Spain

View location on Google Maps